This site requires JavaScript to be enabled. Please enable JavaScript in your browser settings, or upgrade to a modern browser.

International Biotechnology: ‘We are on a recovery now’

Loading player...

Carl Harald Jansen, co-manager of International Biotechnology Trust, talks to Citywire’s Gavin Lumsden about why biotech stocks are making a comeback after a comparatively quiet five years. He explains the revival is not all about finding a cure for Covid-19.

22 Sep 2020 English United Kingdom Investing Citywire

Other recent episodes

Allianz Tech: Wave of trillion-dollar IPOs could dethrone tech leaders

Investors could fund the highly anticipated listings of SpaceX and Anthropic – plus the numerous others on the horizon – by selling the Magnificent Seven giants that have long dominated markets.

3 Jun 24 min

Luke Finch: AI progress is a ‘win win’ for HgCapital

Head of Client Services at European and US software investor Hg, manager of HgCapital, defends the sector against rapid AI advancement.

29 Apr 24 min

Nick Train: Worse-ification is the route to mediocrity

The Lindsell Train manager defends his high-conviction approach that has been ‘wonderful on the upside but painful on the downside’. Despite falling far behind the benchmark in recent years, Train said that ‘in a world of ETFs and index huggers, it is necessary to offer investors a strategy that is…

15 Apr 46 min

We're 'in the early innings' of a biotech recovery

RTW’s Oliver Kenyon unpacks the biotech opportunity as pioneering companies move into commercialisation, and explains why he thinks the sector still looks attractively valued.

17 Feb 31 min

Edinburgh Worldwide’s Simpson-Dent fends off Saba accusations

The Edinburgh Worldwide chair fended off accusations made by Saba Capital ahead of its impending vote to remove the board later this month, defending the £750m trust’s sale of SpaceX and his personal involvement in the FCA’s largest ever fine against a retail company.

8 Jan 24 min

All episodes